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Consultants’ new contract
Shurely shome mishtake?
Editor—I think that there must be a mistake
and I have downloaded the wrong contract
from the BMA’s website.1 The one I
downloaded offers a 4% pay rise in return
for a 16% increase in my clinical workload.
Further pay rises are at the whim of my
managers, to be paid five years in arrears
provided that I meet conditions over which I
have no control or work unpaid overtime.
The contract I downloaded is a licence
to enable my managers to order me in for
routine surgery and clinics on weekday eve›
nings, Saturdays, and Sundays, for no extra
pay, while paying me £1 an hour to be on›
call at other times. Could someone please
send me the other contract that Peter
Hawker and the BMA are hailing as a
resounding victory for my colleagues and
me2 while I vote no to what is clearly a differ›
ent contract.
William Westlake consultant ophthalmologist
Truro TR1 3LX
willandsam@willandsam.fsnet.co.uk
1 Consultant contract: framework. Available at:
www.bma.org.uk/ap.nsf/Content/__Hub + ccsc + contract
(accessed 3 July 2002).
2 Hargreaves S. Government makes U turn on private prac›
tice ban. BMJ 2002;324:1473. (22 June.)
So called victory in private practice
obscures real contractual problems
Editor—Reports on the proposed consult›
ant contract have focused too heavily on the
concessions obtained over private practice
and the headline figure of a 20% pay rise.1
The pitfalls of the contract far outweigh this
victory.
Firstly, few doctors will immediately, or
in the near future, get a 20% rise in pay.
Essentially we are being promised a 20% rise
staged over 20 years, or 1% a year. For many
this rise will be offset in part by loss of domi›
ciliary fees, category 2 work, and the loss of
intensity payments. My own pay rise will be
2›3%—hardly a princely sum given I work
full time for the NHS.
Secondly, the new contract seeks to
make evening working up to 10 pm and
weekend morning work an acceptable part
of the working week, remunerable at
standard rate. I find this appalling. Junior
doctors have spent years fighting to be
remunerated at above the standard rate for
working unsociable hours. Should it be any
different for consultants? And if the aim is to
keep people in hospital medicine why
pursue such family unfriendly initiatives?
Thirdly, too much control is being
handed to managers—both in terms of when
work is done and when salary increments
are paid. The new salary introduces two
forms of performance related pay: the
revamped merit award scheme and the basic
pay spine. Didn’t the BMA fight a long cam›
paign against performance related pay a few
years ago? What happened?
The contract does not fulfil any of its
core objectives. I now feel undervalued by
my employer and my trade union. I want to
retire even earlier. I think a no vote can be
taken as read.
Simon Smith consultant psychiatrist
South Shropshire Community Mental Health Trust,
Ludlow, Shropshire SY8 1DA
si.smith@freeuk.com
1 Hargreaves S. Government makes U turn on private prac›
tice ban. BMJ 2002;324:1473. (22 June.)
Private practice is unlikely to be main
cause of long waiting lists
Editor—The new consultant contract
introduces job plans for hospital consult›
ants1 Full time consultants are to have a
working week made up of 10 “programmed
activities” of “typically four hours each,”
seven of which will be “devoted to direct
clinical care.” The contract also states that
“NHS consultants’ commitment to the NHS
must take priority over any work under›
taken for other organisations.” The clear
implication is that consultants, because of
their perceived focus on earning private
income, are at least one of the causes of
inefficiency and long waiting times, particu›
larly for elective surgery.
In November and December 1997 we
carried out a prospective audit of all elective
general, vascular, urological and breast pro›
cedures in patients scheduled for preopera›
tive assessment or admission to Southamp›
ton University hospitals to establish the
proportion of operations cancelled and for
what reasons. There were no red alerts dur›
ing this time.
Of the 851 patients identified, 847
(99.5%) had data available. Of these, 106
(12.5%) received urgent planned admis›
sions, the remainder being asked to attend a
preoperative assessment clinic. Of these, 61
(8.2%) did not attend. Of those who did
attend, 30 (4%) had their procedures
postponed or abandoned, 22 because of
medical problems and eight because of
social problems or patient preference.
Altogether, 756 patients were scheduled
for admission, including those receiving
urgent planned admission. Of these, 123
(16.3%) had their operations cancelled
before admission, and three failed to attend
hospital on the due date. Eighty five
operations were cancelled because of lack of
a bed, nine because of lack of theatre time,
and six for medical reasons; 13 admissions
were cancelled by patients, and in only 10
was the reason for cancellation not
recorded. Of the 630 patients admitted, a
further nine had their operation cancelled,
five for medical reasons, three because of
lack of theatre time, and one because the
patient refused to give consent. No cases on
which data were available were cancelled
because of the lack of availability of a
surgeon to conduct the operation.
Although this study was carried out in
1997, there has been no material change in
the service provision in most NHS hospitals
since. Anecdotally, Southampton University
Hospitals NHS Trust is typical of most large
teaching hospitals. Lack of beds and theatre
time constitute by far the largest reasons for
cancellation of planned surgical admission.
Increasing the available time of surgeons
will accomplish little without a correspond›
ing increase in the number of available bed
days and theatre hours. The NHS infrastruc›
ture needs urgent attention, not consultant
contracts. Whatever the attitude to the desir›
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ability of private practice, such practice is
unlikely to be a significant cause of long
waiting lists in the NHS.
Steve George reader in public health
John Primrose professor of surgery
University of Southampton School of Medicine,
Southampton, SO9 5NH
pluto@soton.ac.uk
1 Consultant contract: framework. Available at:
www.bma.org.uk/ap.nsf/Content/__Hub + ccsc + contract
(accessed 3 July 2002).
Weak negotiators strike again
Editor—I left the NHS two years ago when
the morale of consultants was, I thought, at
an all time low. We had been rendered
essentially powerless by hospital managers,
were paid a low salary for our expertise and
clinical commitment, and were the victims of
continual government spin depicting us as
lazy, uncaring, unsafe Bentley›driving
moneygrabbers with huge private practices.
I was particularly frustrated that our
representatives, the BMA, repeatedly failed
to assert our real position and always
seemed to climb down when challenged by
negative spin. I can see now that nothing has
changed.1
This new contract is an appalling
deal, and I am astounded that the BMA
negotiators consider it a victory. If you
offered the equivalent deal to any other
professionals, such as barristers or dentists,
they would laugh at you. Hospital porters
would not accept the extension of the
normal working day as proposed in the
contract. Some consultants in the middle
bracket will actually take a pay cut. The only
significant pay rise is the £10 000 for newly
appointed consultants, who, in reality, will
no longer be able to do any significant
private practice as the extra eight hours’
commitment to the NHS will prevent it. The
£10 000, in fact, is not a pay rise because any
consultant doing eight hours a week in the
private sector would make far more than
£10 000 a year.
The BMA negotiators think that the
government has climbed down on the
seven year rule for newly appointed
consultants when, in reality, consultants’ pri›
vate practice has been restricted for life. Any
consultant wishing to pursue private prac›
tice will have less time to do so under the
new contract. He or she will almost certainly
not get the £5000 pay rise every five years
that is given at the discretion of hospital
managers (who now, more than ever, are the
powerbrokers).
In the Republic of Ireland, consultants
are represented by a very strong organis›
ation fronted by people who are not
medically qualified. They are hard negotia›
tors who are not dependent on merit awards
or potential inclusion in the Queen’s
honours list. Thus they act excusively on
behalf of consultants.
If consultants accept this deal, it is only a
matter of time before they will be clocking in
and out with the cleaning and catering staff.
The new contract is an insult to highly
skilled dedicated professionals who have
made significant personal sacrifices to be
where they are today.
Aidan P Gleeson consultant in accident and
emergency medicine
Beaumont Hospital, Dublin, Republic of Ireland
apgleeson@aol.com
1 Hargreaves S. Government makes U turn on private prac›
tice ban. BMJ 2002;324:1473. (22 June.)
New contract means cut in pay for part
time consultants
Editor—I have been a consultant for 14
years. I work part time, seven sessions, and
participate in a 1 in 4 on›call rota. If I trans›
fer to the proposed new contract I will take
an immediate cut in pay of £1000. I will not
regain my current salary level until 2006,
and it will be 2008 before I recoup my lost
earnings. My so called pay rise will begin in
2008›9, an average of 2% per year over the
following five years (subject to managerial
approval and assuming that there are
sufficient funds to afford it. This is the reality
of the proposed new contract for me. It
seems a long way from the headlines of 22
June.1
My vote will be a clear no to the negoti›
ating team’s proposals. The proposed move
to a 40 hour week significantly disadvan›
tages all consultants who work on a less than
full time basis. It would seem the negotiating
team either forgot we exist or believe we are
a low priority group compared with others.
I recommend all consultants who work
part time, particularly those who have been
in post around four or five years, or more,
get out their calculators. You may well find
that your negotiators have negotiated a pay
cut for you.
Diana C Webster consultant
NHS Grampian, Summerfield House, Aberdeen
AB15 2RE
diana.webster@ghb.grampian.scot.nhs.uk
1 Hargreaves S. Government makes U turn on private prac›
tice ban. BMJ 2002;324:1473. (22 June.)
The negotiating committee should come
up with a new agreement
Editor—The framework agreement has
removed our ability to work in a professional
manner and organise activity for the benefit
of our patients.1 The idea of the rigid session
during which attendance in the hospital is
mandatory means that no activity will be
started in future if it might over›run the end
of a session. In addition, there will be no
stimulus to be efficient and get more done as
an early end to the session is now not
rewarded. Although this flexibilty is abused
by a small minority of doctors, the vast
majority use it to organise work as efficiently
as possible.
Am I to be paid for my meal breaks? If
not, I will have to take them as a matter of
right as I would be a complete fool if I
worked over a lunchtime without being paid.
The new contract rewards the clock watcher
and treats the doctor who stays until the job
is done as an idiot. The only staff left on a
professional contract will be managers, and I
am afraid I simply do not trust statements
such as “we would never interpret the
contract in that way.” If it is written down, it
can be enforced.
I do not understand why, as a consultant
of some 14 years, it will take me 23 years
from appointment to reach the salary maxi›
mum, whereas a newly appointed consultant
would take 19. I wrote to Douglas Bilton,
acting secretary of the Central Consultants
and Specialists Committee on this matter
and was told that this was the best that could
be done to bring the deal in under the
financial limits imposed. I have no problem
with new consultants being awarded a
decent salary, but I object strongly to my col›
leagues and me being discriminated against.
We are the group who did a large number of
appalling rotas and did not get the salary or
time off given to current trainees. Why
should we be penalised again? If the contract
needs to be phased in, then an equitable
scheme for all should be sought.
Although the idea of payment for emer›
gency work and so on out of hours is
laudable, sessions to cover onerous on›call
commitments have always been negotiable
locally. All that has happened so far is that
this principle is to be formalised nationally,
but with the loss of recognition of the nature
of unsocial hours.
We can do much better, and for the good
of the service we certainly ought to. The
negotiating committee should take this
framework back.
Crispin Best consultant paediatric anaesthetist
Royal Hospital for Sick Children, Glasgow G3 8SJ
crispin@compuserve.com
1 Consultant contract: framework. Available at:
www.bma.org.uk/ap.nsf/Content/__Hub + ccsc + contract
(accessed 3 July 2002).
Summary of responses
Editor—By 3 July 22 respondents had sent
us 23 responses to the two news items on the
consultants’ new contract.1 2 Sixteen respond›
ents were scattered throughout England,
from Truro to Newcastle; three wrote from
Scotland, and one each from Belfast, Dublin,
and Jersey. Four were consultants in various
subspecialties of anaesthesia or psychiatry,
two were consultant physicians, and two were
consultants in accident and emergency medi›
cine. The 10 other respondents were from a
wide range of disciplines, including academia,
radiology, endocrinology, and clinical neuro›
physiology.
Condemnation of the contract was
unanimous.
Graeme Weiner, a consultant otolaryn›
gologist in Exeter, rushed to read the latest
on the contract in the BMJ of 22 June but
was incredulous to find there was none. He
suggests the journal commission an article
“by a couple of employment law specialists
(and perhaps a human rights lawyer) so that
we may see how truly awful the proposed
framework is.”
Others criticised the use of spin in
reporting the new contract. Lesley Wilson,
consultant old age psychiatrist from Jersey,
said that the BMJ’s headline was unfortunate
and “will tend to support the widely held
Letters
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view that all that consultants are interested
in is keeping their private work.
“Perhaps a better one (though not quite
as catchy) would have been: ‘BMA submits to
government demand that its members work
evenings and weekends for standard rate of
pay.’”
Indeed, has the BMA, and by extension
the BMJ, “fallen victim to the government’s
spin as much as the rest of the media?” asks
consultant physician Guy Clifford from Ket›
tering. Both the extension of normal
working hours and the effective introduction
of performance related pay “are headline
news as far as the 26 000 consultants in the
UK are concerned, but in your most recent
article regarding the new contract, no
mention was made of this. Can there be any
excuse for such biased and poor reporting
of the facts to your own members?”
John Carter, consultant anaesthetist in
Chelmsford, agrees that the main problem
“is the spin being put on this draft, not by the
government (I can live with that), but by my
trade union. I do not want the BMA to ‘sell’
this draft to me. I want the negotiators to go
back to the table and get more. The trainees
did it. We should too.” Change the negotiat›
ing team if necessary, he says.
A lack of accountability and clarity also
militates against acceptance of the new con›
tract.
Negotiations started off well, points out
John Morgan, senior lecturer in psychiatry at
St George’s Hospital Medical School: “As a
public relations exercise, the BMA invited
consultants to pose questions concerning
the new contract with the welcoming words
‘We will attempt to answer all emails
individually.’” But when he did so he found
that the BMA was “unable to enter into
detailed correspondence on an individual
basis.”
“After such a protracted period of nego›
tiation, the BMA should have placed itself in
a position whereby it could answer queries
with speed and accuracy. In failing this, fear
of the unknown will surely cause us all to
vote no.”
James Anderson, consultant radiologist
in Darlington, would be grateful for further
information on what exactly the proposed
contract offers in terms of pensions “as this
subject seems to be couched in rather vague
language” along with the “many clauses pre›
ceded by should, usually, and is expected”
scattered throughout it.
Finally, consultant anaesthetist Michael
Jordan from Ashford, exhorts his fellow
consultants to look closely at the hard copy
of the framework posted to them in the last
week of June: “The cover depicts two prisms
bending light in ways that defy the laws of
optics. There’s a metaphor there some›
where.. . .”
Sharon Davies letters editor, BMJ
1 Electronic responses. Government makes U turn on
private practice ban. bmj.com 2002. (bmj.com/cgi/
content/full/324/7352/1473/a#responses; accessed 3
July 2002.)
2 Electronic responses. Juniors call on consultants to reject
new contract. bmj.com 2002. (bmj.com/cgi/content/full/
324/7352/1478/a#responses; accessed 3 July 2002.)
Gold for the NHS
No natural limitation exists on demand
for services free at point of supply
Editor—By far the most encouraging
sentence in Robinson’s editorial is the last:
“There is a strong case for arguing that . . .
UK healthcare policy should be driven by
the supply side rather than the demand side
reform.”1 Yet there is not a word of this from
the chancellor or the secretary of state or in
the report by Wanless, whose terms of refer›
ence guaranteed his conclusions. Even
working within those limitations Wanless
managed to generate some gratuitous drive,
saying that the cost of health care is likely to
fall as we take greater measures to improve
our health.
There may have been some excuse for
Aneurin Bevan’s assessment of budgetary
realities, but surely 54 years’ unvarying
experience has been enough to convince us
of the truth of another health secretary’s
assessment (Enoch Powell’s): there is no
natural limitation on the demand for any
good or service free at the point of its supply.
Until that is grasped and fully understood,
those working in the NHS will continue to
be the poorly paid providers of inferior care
to an ungrateful public.
Brian Campbell consultant physician
Acute Medicine, Western General Hospital,
Edinburgh EH4 2XU
Kelly.Black@luht.scot.nhs.uk
1 Robinson R. Gold for the NHS. BMJ 2002;324:987›8. (27
April.)
What exactly is being bought with this
gold?
Editor—Two concerns came to me when I
read Robinson’s editorial about the plans for
unprecedented rates of growth in NHS
spending.1
The first is, what exactly is the govern›
ment buying with the extra billions it is
spending on the NHS? Is it hoping to buy
more medical treatment on behalf of the
public? Is it hoping to make the population
healthier by so doing?2 If it is the first of
these then the government has some hope
of achieving its aims, although where the
extra staff are going to be brought from is
not clear. If the government is hoping to
make a difference to the overall health of the
public by spending through the NHS system
it is mistaken. Any treatment system such as
the NHS can only deal with the casualties of
life, not with how to live healthily in the first
place.
This brings me to my second concern:
that simply concentrating on supply side
measures will pander to medical vanity
(treatment as all important) and move
thinking away from looking at how and why
demand for medical services arises in the
first place.
Unless we as individuals and as a society
are able to encompass the full picture of
health, including its environmental factors,
its social relationships, and its political and
moral dynamics, we will continue to find
health puzzling and frustrating. We must
start to examine the sources of demand for
health care and learn to modify them early.
This will require courageous medicine and
courageous politics.
Peter Davies general practitioner
Mixenden Stones Surgery, Halifax HX2 8RQ
npgdavies@doctors.net.uk
1 Robinson R. Gold for the NHS. BMJ 2002;324:987›8. (27
April.)
2 Moore W. NHS to receive an extra £40bn over next five
years. BMJ 2002;324:993. (27 April.)
Postcode prescribing is alive
and well in Scotland
Editor—We had understood that one of the
intentions of the National Institute for Clini›
cal Excellence (NICE) was to rationalise the
introduction of new drugs and technologies
across the United Kingdom so that NHS
patients would have equitable access. This
has plainly not happened. We illustrate the
problem with three recently licensed drugs,
imatinib, irinotecan, and trastuzumab.
Imatinib has yet to be appraised by the
National Institute for Clinical Excellence,
but our local haematologists completed the
paperwork for approval by Lothian Health
Board’s drug evaluation panel. The drug was
not approved. Shortly afterwards the
Scottish Medicines Consortium issued guid›
ance to indicate that it should be made avail›
able: we await the result of an appeal to the
drug evaluation panel. Meanwhile patients
in Fife can get it.
Irinotecan was approved by the National
Institute for Clinical Excellence and the
Health Technology Board for Scotland.
However, the drug evaluation panel for
Lothian has rejected it—despite knowing the
decisions of the institute and the board—on
the grounds that the improved survival does
not justify the cost. If the patients live in the
west of Scotland, however, they can receive
it. In Aberdeen doctors are allowed to
prescribe it but without any additional fund›
ing, so that expenditure on irinotecan com›
petes with that on other drugs.
Trastuzumab was approved by the
institute after a year’s deliberation, and then
by the Health Technology Board for
Scotland. It is already available in the west of
Scotland; but recognising that the real
decision about its availability in the east of
Scotland lies with the Lothian Health
Board, we have to carry out a detailed
assessment of the total cost before applying
to the drug evaluation panel. The only rea›
son we have any optimism about its
decision is that some funding may already
have been identified.
The current system seems no more
equitable than previously; extra layers of
central committees exist, and drug availabil›
ity continues to depend on local health
board decisions. We would advocate a
streamlined approach, with centralised deci›
sion making bodies such as NICE and the
Scottish Medicines Consortium. Any deci›
Letters
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sion in favour of a new drug should result in
automatic top›sliced funding going direct to
the departments dispensing the drugs, so
that clinicians do not have to apply locally
for approval and funding.
The alternative is a return to the old
system of postcode prescribing. This,
however, would require politicians to
acknowledge that local health boards have
the right to set different priorities and are
prepared to take the clinical consequences
of their decisions.
David Cameron senior lecturer in medical oncology
University of Edinburgh and Edinburgh Breast
Unit, Western General Hospital, Edinburgh
EH4 2XU
J Michael Dixon consultant breast surgeon
Edinburgh Breast Unit, Western General Hospital,
Edinburgh EH4 2XU
vCJD: the epidemic that never
was
New variant Creutzfeldt›Jakob disease:
the critique that never was
Editor—Venter’s article on new variant
Creutzfeldt›Jakob disease (vCJD) is intended
to stimulate debate, which we hope will be
better informed than the article itself.1
Is variant Creutzfeldt›Jakob disease a
new disease? Venters places great emphasis
on Creutzfeldt’s case, but this patient did not
have Creutzfeldt›Jakob disease. The illness
was characterised by gait disturbance, a
relapsing and remitting course, nystagmus,
and status epilepticus. These are not the
clinical features of variant Creutzfeldt›Jakob
disease and, crucially, the neuropathological
appearances were “not characterisitic of
Creutzfeldt›Jakob disease.”2
In 1996 confidence in the novelty of
variant Creutzfeldt›Jakob disease was based
largely on the identification of a neuro›
pathological phenotype that was distinct
from that experienced in the United
Kingdom from 1970. Since then archival tis›
sues have been reviewed in many countries
and no past cases with a similar neuropatho›
logical pattern have been found.3 Retrospec›
tive epidemiological surveys in England and
Wales have not identified any missed cases
of variant Creutzfeldt›Jakob disease from
1979›96.4 Current evidence strongly sup›
ports the hypothesis that variant
Creutzfeldt›Jakob disease is indeed a new
disease.
Was variant Creutzfeldt›Jakob disease
identified solely because of improved
surveillance? There was a doubling in the
annual death rates for sporadic Creutzfeldt›
Jakob disease in the United Kingdom
between the 1980s and the 1990s, but simi›
lar increases in the apparent death rates for
sporadic Creutzfeldt›Jakob disease had
occurred in other European countries.5
These countries have been subject to similar
potential improvements in case identifica›
tion, but variant Creutzfeldt›Jakob disease
remains a disease occurring predominantly
in the United Kingdom, despite significant
numbers of young suspect cases being
investigated in each country (figure).
Venters argues correctly that the curve
for the epidemic of variant Creutzfeldt›
Jakob disease does not parallel the number
of cattle with bovine spongiform encepha›
lopathy (BSE) between 1983 and 1988.
However, human exposure to the BSE agent
almost certainly extended to 1996 and
depended on a range of variables not
addressed by his model. These include the
species barrier between cattle and humans,
the numbers of cattle in the final year of the
incubation period, the load of bovine central
nervous tissue entering the human food
chain, the efficiency of legislative measures,
and temporal changes in food production.
Extrapolation from conventional foodborne
epidemics to epidemics of variant
Creutzfeldt›Jakob disease and BSE is clearly
too simplistic.
A wealth of laboratory evidence sup›
ports the hypothesis that the BSE agent is
the cause of variant Creutzfeldt›Jakob
disease.6 Venters states correctly that there is
no direct evidence that the BSE prion is
infectious to humans, but obtaining such
evidence would be difficult to justify ethically
as this would involve inoculating humans
with the agent. A judgment on the link
between BSE and variant Creutzfeldt›Jakob
disease inevitably depends on an assessment
of a range of clinical, pathological, epide›
miological and laboratory based evidence.
There is now overwhelming evidence that
BSE is the cause of variant Creutzfeldt›Jakob
disease, although there remain uncertainties
about the future number of cases and the
mechanism of transmission of BSE to
humans.
R GWill consultant neurologist
R S G Knight consultant neurologist
H J T Ward consultant epidemiologist
J W Ironside director
National Creutzfeldt›Jakob Disease Surveillance
Unit, Western General Hospital, Edinburgh
EH4 2XU
1 Venters GA. New variant Creutzfeldt›Jakob disease: the
epidemic that never was. BMJ 2001;323:858›61.
2 Richardson EP, Masters CL. The nosology of Creutzfeldt›
Jakob disease and conditions related to the accumulation
of PrPCJD in the nervous system. Brain Pathology
1995;5:33›41.
3 Budka H, Dormont D, Kretzschmar H, Pocchiari M, van
Duijn C. BSE and variant Creutzfeldt›Jakob disease: never
say never. Acta Neuropathol 2002;103:627›8.
4 Majeed A, Lehmann P, Kirby L, Knight R, Coleman M.
Extent of misclassification of death from Creutzfeldt›Jakob
disease in England 1979›96: retrospective examination of
clinical records. BMJ 2000;320:145›7.
5 Will RG, Alperovitch A, Poser S, Pocchiari M, Hofman A,
Mitrova E, et al. Descriptive epidemiology of Creutzfeldt›
Jakob disease in six European countries, 1993›1995. Ann
Neurol 1998;43:763›7.
6 Zeidler M, Ironside JW. The new variant of Creutzfeldt›
Jakob disease. Rev Sci Tech Off Int Epiz 2000;19:98›120.
Creutzfeldt’s patient did not have
Creutzfeldt›Jakob disease
Editor—Venters uses Creutzfeldt’s original
case report of 1921 as an argument against
the existence of a ‘‘new” variant of
Creutzfeldt›Jakob disease (CJD).1 Creutzfeldt
described a patient who presented to his
department aged 23.
She was the youngest of five children,
two of whom had mental retardation. The
patient’s parents were both dead, the cause
or date of the father’s death was not known,
the mother had died of a “non›neurological”
disease when the patient was 14. In her late
adolescence, the patient was thought to be
odd, as she continued to play with dolls and
exhibit other childlike behaviour. Aged 21,
she refused to eat, claiming that she wanted
to lose weight. At the same time, her gait was
noted to be “heavy.” Aged 22 she developed
a symmetrical rash affecting her face, later
also both hands, her groin, and both feet.
She was found to have spastic legs and
tremor in all limbs. While on a dermatology
ward she had a “hysterical seizure” with arc
de cercle. It is not clear how she was treated,
but all of her symptoms, including the gait
disorder, improved.
One year later the gait deteriorated
again. At the same time the patient refused
to eat or wash, complained about chest
pains, and exhibited agitated and paranoid
behaviour or inappropriate laughter. On
admission to the neurology department she
was pyrexic at 38.9°C, incoherent and not
oriented in time or space. Her speech had a
staccato quality. She had myoclonic limb
jerks, intention tremor, nystagmus, increased
limb tone, brisk tendon jerks, hyperaesthe›
sia, and hyperalgesia. She gradually deterio›
rated over three months and died in status
epilepticus characterised by tonic seizures,
seizures with Jacksonian march, and clonic
jerks.
From a clinical point of view, family his›
tory, relapsing course, and skin rash would
argue against a diagnosis of “variant” or spo›
radic Creutzfeldt›Jakob disease. More
importantly perhaps, Creutzfeldt’s meticu›
lous histopathological report does not men›
tion spongiform change (conspicuous in
almost all known cases of Creutzfeldt›Jakob
disease) or florid plaques (one of the
hallmarks of variant Creutzfeldt›Jakob dis›
ease).2 Creutzfeldt’s original pathology slides
were reviewed by Jakob who thought the
changes were identical to those seen in two
of his own patients.3 4
The tissue from Jakob’s two patients was
reviewed by the neuropathologist C L
Masters in 1982, who found that these
patients of Jakob’s did not have any evidence
of a spongiform encephalopathy. Only his
later patients had changes typical of
Creutzfeldt›Jakob disease.5 The first two
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patients certainly did not have new variant
Creutzfeldt›Jakob disease. Perhaps we
should drop the “C” from Creutzfeldt›Jakob
disease.
Markus Reuber specialist registrar
Department of Neurology, Leeds Teaching Hospital
NHS Trust, Leeds LS9 7TF
mreuber@doctors.org.uk
1 Venters GA, New variant Creutzfeldt›Jakob disease: the
epidemic that never was. BMJ 2001;323:858›61.
2 Creutzfeld HG. Ueber eine eigenartige Erkrankung des
Zentralnervensystems. Z ges Neurol Psychiat 1920;57:1›18.
3 Jakob A. Ueber eigenartige Erkrankungen des Zentralner›
vensystems mit bemerkenswertem anatomischem
Befunde (Spastische Pseudosklerose›Encephalo›
myelopathie mit disseminierten Degenerationsherden). Z
ges Neurol Psychiat 1921;64:147›228.
4 Richardson EP, Masters CL. The nosology of Creutzfeldt›
Jakob Disease and conditions related to the accumulation
of PrPcjd in the nervous system.Brain Pathol 1995;5:33›41.
5 Masters CL, Gajdusek DC. The spectrum of Creutzfeldt›
Jakob disease and the virus›induced subacute spongiform
encephalopathies. In: Smith WT, Cavanagh JB, eds. Recent
advances in neuropathology. Edinburgh: Churchill Living›
stone, 1982:139›63.
Possibility of BSE being cause of variant
CJD is indeed biologically plausible
Editor—Venters argued against bovine
spongiform encephalopathy (BSE) causing
variant Creutzfeldt›Jakob disease.1 In fact,
the biological plausibility of this being the
cause, the strength of the epidemiological
association, and the experiments indicating
that the same prion is involved are all good.
Incubation periods for BSE are propor›
tional to the life expectancy of the animal
affected. The disease’s incubation period is
18% of a cow’s life expectancy and would be
expected to about double when crossing to
another species—that is, to 36% of 70 years
in humans. Thus the incidence of a disease
due to BSE in humans would be predicted
to peak in 2014. A few human cases would
be seen before 2000 and none early in the
1990s. Small outbreaks would be expected
early in the epidemic before they become
lost among a high background prevalence.2
The pattern of variant Creutzfeldt›Jakob dis›
ease cases fits this.
Everyone in the United Kingdom has
eaten on average over 50 meals of the tissues
of cattle infected with BSE; this figure would
be lower in other countries. The novelty of
variant Creutzfeldt›Jakob disease is not now
questioned as it is different from kuru on
histopathological grounds and scrapie
prion (PrPsc) biochemistry. No similar cases
before 1995 have been found.3
BSE infects a different range of animals
from scrapie and infected all the species
inoculated experimentally except chickens
and hamsters. It is reasonable that it might
infect humans. When fed BSE, 25% of
sheep, 33% of goats, 50% of kudu, 100% of
mice, and 100% of mink died. Calculating
this percentage for humans is difficult as it is
early in the epidemic.2
BSE prion doses to which humans may
have been exposed might well cause large
numbers to become infected despite the
inefficiency of the oral route. Beef exported
from the United Kingdom to France was
mainly older animals, specific tissues, and
calves. This means that there was a relatively
high dose of prions per meal in France, and
this fits the number of cases of variant
Creutzfeldt›Jakob disease seen there.2 Why
younger people are apparently becoming
infected is not clear, but this does not mean
that BSE is not the cause.
Identical pathology and PrPsc glyco›
forms are produced in mice when variant
Creutzfeldt›Jakob disease, BSE, or feline
spongiform encephalopathy is inoculated.
This is exceptional evidence that the same
prion is the cause.4 PrPsc associated with
BSE will alter human normal prion protein
to the abnormal form in vitro,5 but it is not
surprising that transgenic mice expressing
human prion protein did not become
infected easily with BSE.
Steve Dealler consultant in medical microbiology
Burnley General Hospital, Burnley BB10 2PQ
deal@airtime.co.uk
1 Venters GA. New variant Creutzfeldt›Jakob disease: the
epidemic that never was. BMJ 2001;323:858›61.
2 Dealler SF. Should young UK cattle be considered free of
BSE or is it endemic? Br Food J 2001;103:264›80.
3 McLean CA, Ironside JW, Alpers MP, Brown PW, Cervena›
kova L, Anderson RM, et al. Comparative neuropathology
of kuru with the new variant of Creutzfeldt›Jakob disease:
evidence for strain of agent predominating over genotype
of host. Brain Pathol 1998;8:429›37.
4 Bruce ME, Will RG, Ironside JW, McConnell I, Drummond
D, Suttie A, et al. Transmissions to mice indicate that ‘new
variant’ CJD is caused by the BSE agent. Nature
1997;389:498›501.
5 Raymond GJ, Hope J, Kocisko DA, Priola SA, Raymond
LD, Bossers A, et al. Molecular assessment of the potential
transmissibilities of BSE and scrapie to humans. Nature
1997;388:285›8.
Author has overlooked several findings
that support his argument
Editor—Venters’s reappraisal of variant
Creutzfeldt›Jakob disease (vCJD) is impor›
tant1 because, even if new cases of the
disease continue to be reported sporadically
or in an occasional cluster, there is no
evidence of an epidemic anywhere.2 But in
dismissing the misfolded prion glycoprotein
that “causes” bovine spongiform encepha›
lopathy (BSE) as the cause of variant
Creutzfeldt›Jakob disease in humans Ven›
ters overlooks other findings that support
his argument.3
Firstly, BSE began in dairy herds in
1986, almost immediately after the Ministry
of Agriculture, Fisheries and Food removed
controls on foodstuffs for cattle and
mandated supplementary feeding with pro›
teinaceous offal, often containing scrapie
material, to increase milk production.
Secondly, suckler›fed, grass›fed pedigree
herds were virtually unaffected unless they
were in contact with dairy cattle.
Thirdly, BSE subsided when supplemen›
tary feeding with proteinaceous offal was
banned.
Fourthly, ascertainment of unprec›
edented intensity has shown an excess of all
five forms of Creutzfeldt›Jakob disease in the
United Kingdom since 1989 but no excess
of variant Creutzfeldt›Jakob disease in those
at high, continuous, and percutaneous risk
of occupational exposure to actual BSE—
namely, veterinarians, and people working
on farms and in cattle markets, abattoirs,
butchers’ shops, and canteens.
Fifthly, the same ascertainment has
identified variant Creutzfeldt›Jakob disease
in younger people with questionable levels
of presumed exposure from ingestion of
cooked beef or beef products possibly
containing BSE prion. An increase in
incidence, from 0.8 confirmed cases per mil›
lion in 1995 to 1.2 in 2000, is continuing,
along with an overall increase in total
(including iatrogenic) referrals but a
decrease in all other forms of Creutzfeldt›
Jakob disease. Surveillance of relevant
neurological disease in children in the
United Kingdom since 1997 has yielded
only three cases, although suspect prion is
present in tonsils.
Prusiner and his team give reasons for
regarding scrapie prion as the common
cause of BSE.4 But there are genetic and
other reasons, as above, for questioning
the hypothesis that BSE is directly trans›
missible to humans. Although published as
a witness statement in the BSE enquiry,3
these reasons were not discussed in the
ensuing (Phillips) report, which preferred to
conclude that BSE originated as a mutant of
scrapie prion in the 1970s.5 It was content to
accept common causation on the basis of
endpoint similarities in neuropathological
features of variant Creutzfeldt›Jakob disease
and BSE, as observed in cattle and in
transgenic mice bred with the gene for
BSE prion and then inoculated intra›
cerebrally with brain material from cattle
with BSE.
Factual evidence about the revolution in
animal feeding and the nil incidence of vari›
ant Creutzfeldt›Jakob disease in close
human contacts at highest risk is giving way
to artefactual experimental results in mice
supporting a hypothesis that BSE prion
can cross a further species barrier to cause
variant Creutzfeldt›Jakob disease in
humans.2 3 5 6 This is the scientific hypothesis
now used to maintain speculation that
anyone who eats British beef or beef
products has a lifetime risk—at present,
1.2›1.5 per million persons per annum2 6—of
developing variant Creutzfeldt›Jakob dis›
ease and starting an epidemic.
Gordon T Stewart emeritus professor of public health,
University of Glasgow
29/8 Inverleith Place, Edinburgh EH3 5QD
g.stewart@gifford.co.uk
1 Venters GA. New variant Creutzfeldt›Jakob disease: the
epidemic that never was. BMJ 2001;323:858›61.
2 Scottish Executive. Health Bulletin 2001;59(6):70.
3 Stewart GT. Witness statement to the BSE enquiry 2000.
www.bse.org.uk refs 586 and 586 annex.
4 Peretz D, Williamson RSA, Klotoshi K, Vergara J, Leclerc E,
Schmit›Ulms G, et al. Antibodies inhibit prion propaga›
tion and clear cell cultures of prion infectivity. Nature
2001;412:739›43.
5 Following through on Phillips (report of the BSE inquiry).
Nature 2000;408:1.
6 Stewart GT. More on BSE/CJD. J R Soc Med 2002;95:112.
Has medicalisation of
childbirth gone too far?
Regional analgesia in labour permits
childbirth without fear
Editor—Several points in Johanson et al’s
review on the medicalisation of childbirth
deserve comment.1 Firstly, maternal mor›
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tality related to anaesthesia has declined
dramatically over the past few decades.
Recent surveys from both the United
Kingdom and the United States find that the
few fatal complications of anaesthesia in
obstetrics are usually related to complica›
tions of general anaesthesia—for example,
loss of airway or hypoxia.2 3
The decline in the use of general anaes›
thesia for caesarean delivery must partly be
attributed to the rise in use of regional anal›
gesia during labour.4 In fact, the American
College of Obstetricians and Gynecologists
has issued a statement saying: “Failed
intubation and pulmonary aspiration of gas›
tric contents continue to be leading causes
of maternal morbidity and mortality from
anesthesia. The risk of these complications
can be reduced by careful antepartum
assessment to identify patients at risk,
greater use of regional anesthesia when pos›
sible, and appropriate selection and prepa›
ration of patients who require general
anesthesia for delivery.”5
Johanson et al’s paper states that women
are “encouraged” to receive epidural analge›
sia in labour. This paternalistic attitude
ignores the fact that most women in labour
choose epidural analgesia of their own voli›
tion, without influence. I believe firmly that
the choice for women to elect to undergo
natural childbirth should always be available
(within the limits of safety with regard to
certain high risk conditions), just as some of
us choose to climb mountains or run mara›
thons. This should also be accompanied by
the attitude among all obstetric and anaes›
thetic care providers that there is nothing
“wrong” with women who choose natural
childbirth.
But most people do not run marathons
or climb mountains. And most women do
not want to have pain during childbirth. The
widespread use of regional analgesia in
labour should be celebrated as one of the
blessings of having a baby in this millen›
nium. Pain free childbirth has become as
much a part of modern culture as the
mobile phone or the microwave oven.
Johanson et al state that “Childbirth
without fear should become a reality for
women, midwives, and obstetricians.” As one
of the cardinal fears of labour is pain, the
widespread availability and use of regional
analgesia should go a long way towards
reducing this fear.
William Camann director of obstetric anesthesia
Brigham and Women’s Hospital, Harvard Medical
School, Boston, MA 02115, USA
wcamann@partners.org
1 Johanson R, Newburn M, Macfarlane A. Has medicalisa›
tion of childbirth gone too far? BMJ 2002;324:82›5. (13
April.)
2 De Swiet M. Maternal mortality: confidential enquiries into
maternal deaths in the United Kingdom. Am J Obstet Gyne›
col 2000;182:760›6.
3 Hawkins JL, Koonin LM, Palmer SK, Gibbs CP.
Anesthesia›related deaths during obstetric delivery in the
United States, 1979›1990. Anesthesiology 1997;86:277›84.
4 Tsen L, Pitner R, Camann W. General anesthesia for cesar›
ean delivery at a tertiary care hospital. Int J Obstet Anesth
1998;7:147›52.
5 American College of Obstetricians and Gynecologists.
Anesthesia for emergency deliveries. Washington, DC: ACOG,
1992. (ACOG committee opinion No 104.)
Timely intervention is the key
Editor—Johanson et al imply that medicali›
sation of childbirth has led to a high caesar›
ean section rate and quote data from
Catalonia to Ontario.1 They have forgotten
their neighbours in the Republic of Ireland,
where active management of labour is prac›
tised in some units.2 The National Maternity
Hospital in Dublin, for instance, boasts a
section rate that has been consistently
among the lowest in developed nations.
Strict criteria for the diagnosis of labour,
early amniotomy, use of oxytocin, and the
involvement of a senior obstetrician at an
early stage are cornerstones of the active
management of labour. In addition, units in
Dublin believe strongly in patient choice,
and epidural analgesia is widely used. Do
Johanson et al not consider these interven›
tions to be medicalisation?
Active management of labour was
designed primarily to reduce morbidity (and
mortality) associated with prolonged
labour—something that most obstetricians
of the present generation seem to have
forgotten about. One of the side effects of
the active management of labour is a reduc›
tion in the caesarean section rate.
Surely the authors must accept that
some of the reasons why the United
Kingdom has a high section rate has to do
with the fact that we don’t know how to
diagnose labour (ask any midwife or
obstetrician and you will get a myriad of
responses) and we don’t know when to per›
form an amniotomy, use oxytocin, or involve
a senior obstetrician.
No, the problem isn’t that the medicali›
sation of childbirth has gone too far; rather,
it’s that we don’t know when to intervene. We
agree with the authors that visits to other
units and countries should be encouraged.
More of us should travel across the Irish Sea.
Meh›Noi Lim senior house officer in obstetrics and
gynaecology
Walsgrave Hospital, Coventry CV2 2DX
mehnoi@hotmail.com
Stephen Ong clinical research fellow
Nottingham City Hospital, Nottingham NG5 9PB
1 Johanson R, Newburn M, Macfarlane A. Has the medicali›
sation of childbirth gone too far? BMJ 2002;324:892›5. (13
April.)
2 O’Driscoll K, Meagher D, Boylan P. Active management of
labor. London: Mosby, 1993.
Childbirth in Taiwan is certainly
overmedicalised
Editor—Taiwan has transformed itself from
a developing to a developed country in
recent decades.1 As it has done so, medical
resources have improved dramatically and
now compare favourably with those of any
Western industrialised nation.
Alas, in childbirth, medicalisation has
taken hold throughout the obstetric profes›
sion. Nearly every intervention in childbirth
is perceived as necessary and good. For
example, on entering a delivery suite
pregnant women undergo a routine enema,
routine pubic shaving, routine nil by mouth,
routine intravenous cannulation, and rou›
tine intravenous hydration. The paternalistic
approach is the norm.
Pregnant women at term with rupture of
membranes before labour are subjected to
routine induction of labour. Again, the
paternalistic approach offers no choice.
Expectant management for even the next
12›24 hours is perceived as too risky an
alternative. Even pregnant women at 36
weeks’ gestation are subjected to the same
routine protocol.
All women in labour undergo routine
midline episiotomy. Every woman is sub›
jected to this regardless of gestation (term or
preterm). The episiotomy rate approaches
100%.
The above practices are so entrenched
that any change of practice would meet
much resistance. Increasing medicalisation
has led not to diminishing but to increasing
numbers of medicolegal cases. A vicious
cycle ensues. Obstetricians now act and
intervene even more for fear of litigation.
Government health statistics show that
the number of registered midwives declined
in the past decade, from 1891 in 1990 to a
mere 558 in 2000. During the same period
the number of registered doctors rose from
19 921 in 1990 to 29 585 in 2000. This is for
a population of 20 million in 1990 and 22
million in 2000.2
As Taiwan now seeks observer status in
the World Health Organization, professional
bodies and governments in Taiwan should
promote obstetric practice as contained in
the WHO report Care in Normal Birth: A
Practical Guide, which aims at improving
obstetric practice in normal childbirth.3
Peter S Yeh senior resident in obstetrics and
gynaecology
Taiwan Adventist Hospital, Taipei 105, Taiwan
yehpeter@hotmail.com
1 Chiang T›L. Economic transition and changing relation
between income inequality and mortality in Taiwan—
regression analysis. BMJ 1999;319:1162›5.
2 Department of Health. Health and vital statistics. Taiwan,
Republic of China: Department of Health, 2000.
3 World Health Organization.Care in normal birth—a practical
guide. Geneva: WHO, 1996.
Evolving general practice
consultation in Britain
Increasing consultation time may not be
straightforward
Editor—Freeman et al plead for longer
consultations in British general practice.1 A
pilot study performed with six general prac›
titioners in Glasgow shows that breaking the
habit of short consultations may be difficult
and longer consultations may lead to higher
health service costs.
Our study piloted a randomised control›
led trial of the effect of an increased booking
interval on identification of the patient’s psy›
chological distress.2 Each doctor’s surgery
was randomised to either 10 minutes per
patient (the normal booking interval) or 15
minutes. One of us (MS) offered locum
sessions to make up the shortfall in available
consultations. We recorded 65 consultations
at each booking interval for each prac›
titioner. After the consultation, patients
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completed the general health questionnaire›
12; doctors estimated psychological distress
using a six point scale and recorded impor›
tant outcomes of the consultations. Consul›
tations were timed by a research assistant.
Data were collected from 781 consulta›
tions. When booking interval was increased
by 50% consultation length increased by
12%, from 8.7 minutes to 9.7 minutes.
Longer booking intervals significantly
increased the number of consultations in
which the doctor arranged investigations
(19.4% v 27.9%; P = 0.0069) and follow up
appointments (43.8% v 53.7%; P = 0.0072).
There was no significant effect on the
proportion of consultations in which pre›
scriptions were issued (51.0% v 54.7%;
P = 0.34), physical examination carried out
(66.8% v 66.8%; P = 0.96), or referral made
(14.0% v 10.7%; P = 0.20).
There were no significant differences in
identification of psychological distress
between long or normal booking intervals
(odds ratio 1.00 (95% confidence interval
0.63 to 1.59)).
Although booking interval increased by
50%, consultation length increased by only
12%. This raises the question of what the
doctors did with the extra time. It has been
argued that increasing the length of consul›
tations will save time and resources. Our
results suggest that the opposite is true; doc›
tors ask more patients to make follow up
appointments after longer consultations and
perform more investigations. Perhaps doc›
tors given more time with patients simply
uncover more problems. The lack of impact
of an increased booking interval on the rec›
ognition of psychological distress in patients
suggests that structural constraints are insuf›
ficient to explain low rates of recognition of
distress by general practitioners.
Our results must be interpreted with
caution. A more sustained intervention
might have led to more major changes in
consulting behaviour. Our data suggest,
however, that longer consultation intervals
may cost more than remuneration for extra
general practitioners’ time.
Phil Wilson general practitioner
p.wilson@clinmed.gla.ac.uk
Alex McConnachie statistician
Department of General Practice, University of
Glasgow, Glasgow G12 0RR
Mark Stirling general practitioner
Ferguson Medical Practice, Broxburn Health
Centre, Broxburn EH52 1JZ
1 Freeman GK, Horder JP, Howie JGR, Hungin AP, Hill AP,
Shah NC, et al. Evolving general practice consultations in
Britain: issues of length and context. BMJ 2002;324:880›2.
(13 April.)
2 Stirling M, Wilson P, McConnachie A. Consultation length,
deprivation and identification of psychological distress in
general practice. Br J Gen Pract 2001;51:456›60.
Longer consultations might necessitate
redeployment of pharmacists
Editor—Freeman et al open an overdue
debate about the length of consultation
times.1 They address the question of why
consultations should be longer but do not
consider how this might be achieved.
The workload in primary care is increas›
ing faster than the workforce is. This is
fuelled partly by demography, partly by
increased health expectations, and partly by
developments in treatment. The unremitting
commercial gamesplaying of the pharma›
ceutical industry, highlighted in an article in
the same issue of the BMJ as Freeman et al’s
article, adds another turn to this screw.2
General practitioners are fully occupied.
There is no prospect of a huge increase in
the general practitioner workforce in the
next decade. The only way for doctors to
have more time is therefore for them to stop
doing things.
There are a few activities that general
practitioners might simply stop doing. Some
may need legislative change, such as a move
from repeat prescribing to repeat dispens›
ing.3 This would probably save the average
general practitioner about an hour a day.
Other changes might need us to question
some of our routine behaviours perpetuated
by the convoluted fee structure of general
medical services. Why do we need to see
patients taking contraceptives twice a year?
Why do we still dabble in antenatal care
when midwives do it so much better? What
is a “full postnatal examination” for?
The most effective way of freeing up
time is to delegate. Get someone else to do
it—preferably someone who is better at it
than you are. The extended roles of practice
nurses and nurse practitioners are a move in
this direction, but there are so many calls on
nurses that we are probably close to the limit
of available staff. The largest untapped
source of underused skill, however, is
community pharmacists: the fact that so
many are trapped behind their counters
selling baby food and offering cold remedies
of questionable efficacy is a waste of their
clinical skills.
The future of the traditional high street
pharmacy is threatened by the pincer move›
ment of industrialised warehouse dispens›
ing and the supermarket pharmacy. At
present supermarket pharmacies are con›
tributing to a manpower shortage, but ware›
house dispensing could reverse this trend.
The potential exists to redeploy pharmacists
into general practices to review patients and
supervise drugs, making best use of their
knowledge and developing skills.4 5 This
would free up general practitioners and
enable them to extend consultations and
improve the depth and breadth of care.
Arnold G Zermansky general practitioner
A.G.Zermansky@leeds.ac.uk
David K Raynor head, Pharmacy Practice and
Medicines Management Group
Duncan Petty research pharmacist
School of Healthcare Studies, University of Leeds,
Leeds LS2 9UT
Nick Freemantle professor of clinical epidemiology
and biostatistics
Department of Primary Care and General Practice,
University of Birmingham, Birmingham B15 2TN
1 Freeman GK, Horder JP, Shah NC, Howie JG, Hungin A,
Hill AP, et al. Evolving general practice consultation in
Britain: issues of length and context. BMJ 2002;324:880›2.
(13 April.)
2 Moynihan R, Heath I, Henry D. Selling sickness: the phar›
maceutical industry and disease mongering. BMJ
2002;324:886›91. (13 April.)
3 Department of Health.Pharmacy in the future › implementing
the NHS national plan. London: DoH, 2000.
4 Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail
A, Lowe C. Randomised controlled trial of clinical
medication: review by a pharmacist of elderly patients
receiving repeat prescriptions in general practice BMJ
2001;323:1340.
5 Mason JM, Freemantle N, Nazareth I, Eccles M, Haines A,
Drummond MF. When is it cost›effective to change the
behavior of health professionals? JAMA 2001;286:
2988›92.
The lot of airline pilots and
consultants is not so different
Editor—A day in the life of a hospital con›
sultant: is it so different from that of an
airline pilot?1 Awake from a restless night.
Study the latest directive from the flying tsar.
Finish off writing lecture notes on emer›
gency landing procedures. Set off to airport
via a charity coffee morning to receive
cheque to buy a new pilot seat.
Arrive Stansted. Pilots’ car park full of
ground crews’ cars, so have to park some
way away and walk to check›in.
Take morning flight to Paris. Mid›
channel find out that there is only one
trained air steward in the cabin and the rest
are steward assistants; go back to help.
Standing room only because of 30 over›
bookings.
Land; sprint across tarmac and take
9 am flight to Copenhagen. During flight do
two appraisals of navigators, answer 10 writ›
ten complaints about cuisine, and lecture
flight staff about latest safety procedures.
Land at Copenhagen. Race across
tarmac and take 11 15 am flight to Brussels.
Land 1 pm on two sets of wheels as one set
now 15 years old (application to lottery fund
for new set failed). Receive round of
applause for good landing and a writ from a
passenger whose duty free goods fell on his
head.
Take flight to Athens. Co›pilot is new
style trainee with 10 minutes’ flying experi›
ence. During flight talk down two other
landings because staff are inexperienced.
Arrive Athens 3 pm. Immediate turn›
round. Flight back to London Stansted
7 pm. Find car wheel clamped. No problem
as bleep went off and I had to take
emergency cargo flight to Glasgow. Big
bonus: I was able to wave goodnight to the
children as I flew over the house. Arrive
Glasgow in the early hours of the morning;
canteen shut so grab stale sandwich from
vending machine and try to grab an hour’s
sleep in airport terminal chair.
Still, it was better than yesterday.
Colin Trask consultant in radiotherapy and oncology
Southend Hospital, Southend SS0 0RY
colin.trask@southend.nhs.uk
1 McDonald E. One pilot son, one medical son. BMJ
2002;324:1105. (4 May.)
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